Safety risks: It becomes difficult to manage precise dosing, which can lead to complications like severe dehydration
Recent early phase clinical trials have demonstrated a higher percentage of MASH resolution in patients who were treated with GLP-1 agonists compared to placebo, although they have not yet shown a statistically significant improvement in fibrosis stage 9
The Retatrutide data strengthen Eli Lilly's long-term investment case
Interestingly, L585 could only be replaced with an amino acid having similar physiochemical properties, including isoleucine, methionine, and valine, without negatively affecting FcRn binding 64
Systemic lithium administration alters rat cerebral cortex phospholipids Biol Psychiatry 1987
I'm vegan and always tired